Tekton Research has launched its first clinical research hub in San Antonio, Texas, enhancing its capabilities in cardiometabolic research and patient-centered metabolic care. This new facility will be led by Dr. Jara McDonald, MD, FAAFP, DABOM, who is double board-certified in Family Medicine and Obesity Medicine. The hub aims to leverage a multidisciplinary team of specialists, including Dr. Arti Thangudu, a triple board-certified physician in Endocrinology, Diabetes, and Metabolism, to conduct a wide array of clinical studies across various therapeutic areas.

The establishment of this hub is significant for advancing clinical research in cardiometabolic conditions, particularly obesity and diabetes, which are critical areas in longevity science. The facility is equipped with four dedicated exam rooms and a participant database of over 12,000 individuals, allowing for efficient enrollment and robust study execution. By focusing on sustainable behavior and lifestyle changes, the San Antonio hub aims to address chronic conditions and promote healthspan improvements through innovative treatment approaches.

The opening of this hub shifts the landscape of clinical trial execution by fostering multispecialty collaboration and expanding research capabilities in a centralized location. This model not only enhances the potential for high-quality data collection but also accelerates the development timelines for new therapies targeting chronic diseases. As Tekton Research continues to expand its footprint with additional hubs in Dallas, Austin, and Oklahoma City, the integration of diverse therapeutic expertise will likely lead to more comprehensive and impactful clinical studies in the longevity and healthspan research fields.

Source: globenewswire.com